In focus · trending topic

clinicaltrial

50 stories · following the connections

Abeona to Present At Multiple Upcoming Conferences

By Nasdaq OMXApr 20, 2017, 12:05 PM UTC

Abeona Therapeutics Reports Q4 2016 Financial Results and Business Highlights

By Nasdaq OMXMar 31, 2017, 12:05 PM UTC

Abeona Therapeutics to Present at Multiple Upcoming Investor Conferences

By Nasdaq OMXMar 13, 2017, 12:15 PM UTC

Abeona Therapeutics Receives Orphan Drug Designation in the European Union for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa

By Nasdaq OMXMar 8, 2017, 1:15 PM UTC

Abeona Therapeutics To Present At The Cowen and Company 37th Annual Health Care Conference

By Nasdaq OMXMar 7, 2017, 12:45 PM UTC

Abeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in Shanghai

By Nasdaq OMXMar 3, 2017, 12:44 PM UTC

Abeona Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference and 3rd Annual CRISPR Congress

By Nasdaq OMXFeb 21, 2017, 12:48 PM UTC

Abeona Therapeutics Provides Update from ABO-102 Phase 1/2 MPS IIIA Clinical Trial at the 13th Annual WORLDSymposium™ 2017

By Nasdaq OMXFeb 17, 2017, 12:45 PM UTC